The larger isoform of the enzyme glutamate decarboxylase, GAD67, synthesizes >90% of basal levels of ␥-aminobutyric acid (GABA) in the brain. In contrast, the smaller isoform, GAD65, has been implicated in the finetuning of inhibitory neurotransmission. Mice deficient in GAD65 exhibit increased anxiety-like responses in both the open field and elevated zero maze assays. Additionally, GAD65-deficient mice have a diminished response to the anxiolytics diazepam and pentobarbital, both of which interact with GABA-A receptors in a GABA-dependent fashion to facilitate GABAergic neurotransmission. Loss of GAD65-generated GABA does not appear to result in compensatory postsynaptic GABA-A receptor changes based on radioligand receptor binding studies, which revealed no change in the postsynaptic GABA-A receptor density. Furthermore, mutant and wild-type animals do not differ in their behavioral response to muscimol, which acts independently of the presence of GABA. We propose that stress-induced GABA release is impaired in GAD65-deficient mice, resulting in increased anxiety-like responses and a diminished response to the acute effects of drugs that facilitate the actions of released GABA.
␥-Aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in the mammalian nervous system. It is synthesized by two isoforms of glutamic acid decarboxylase, GAD65 and GAD67 (1). The two isoforms, which are coexpressed in GABAergic neurons, differ with respect to cofactor association and subcellular distribution (2, 3) . GAD67 is found mainly in the cell body, tightly associated with the cofactor pyridoxal 5Ј-phosphate, whereas GAD65 is associated mainly with nerve termini, reversibly anchored to the membranes of synaptic vesicles (4) (5) (6) . Additionally, GAD65 is found at high levels in an apo-enzyme form, which can be activated on cofactor addition (7, 8) . Thus, it has been suggested that GAD67 is responsible for the maintenance of basal GABA levels, whereas GAD65 can be rapidly activated in times of high GABA demand (8) .
Distinct roles for the two isoforms are further suggested by the phenotypes of GAD65-deficient and GAD67-deficient mice. We and others have shown previously that lack of GAD65 results in a viable phenotype (9, 10) . Brains of GAD65Ϫ͞Ϫ mice exhibit a 50% decrease in cofactor-inducible GAD enzymatic activity (9) . Yet, young GAD65-deficient mice on the C57BL͞6 background exhibit only a slight decrease in brain GABA levels, and adult GAD65-deficient mice exhibit normal GABA content in cortex, cerebellum, and hippocampus (9, 11) , indicating that the only remaining isoform of GAD (GAD67) can maintain wild-type GABA levels. Our study revealed that GAD65-deficient mice on the C57BL͞6 background are susceptible to infrequent spontaneous and stress-induced seizures. This phenotype is in sharp contrast to GAD67-deficient mice, which exhibit a perinatal lethal phenotype (12, 13) . Brains of newborn GAD67Ϫ͞Ϫ mice have only 7% of wild-type levels of GABA at birth, consistent with an inability of the GAD65 protein to produce sufficient GABA for survival.
GABA-A receptors are the predominant receptors for GABAergic neurotransmission (see ref. 14) . GABA binds to GABA-A receptors at the GABA binding site and increases the neuronal membrane conductance for Cl Ϫ ions, which results in membrane hyperpolarization (15, 16) . This hyperpolarization, in turn, leads to reduced neuronal excitability. GABA agonists, such as muscimol, interact directly with the GABA binding site to activate Cl Ϫ conductance, and thus function independently of GABA (17) . Pentobarbital and other barbiturates allosterically enhance GABAergic neurotransmission by increasing the mean channel open time in a GABA-dependent fashion (18) . Diazepam and other benzodiazepines enhance the actions of GABA at the GABA-A receptor by increasing the probability of Cl Ϫ channel opening (16, 19) and Cl Ϫ conductance (20) . Agents that facilitate GABAergic neurotransmission are typically anxiolytic, whereas agents that inhibit GABAergic neurotransmission are anxiogenic (for reviews see refs. 21 and 22 and references therein). For example, the positive modulators of GABAergic neurotransmission [benzodiazepines (23) (24) (25) , and barbiturates (26) ], have been shown to produce anxiolytic-like effects in rodent ethological models of anxiety. In contrast, the GABA-A receptor antagonists bicuculline (25) and picrotoxin (27) exhibit anxiogenic-like effects.
Here, we have assessed anxiety-related behaviors and responses to GABA-A receptor modulators in GAD65-deficient mice. We show that GAD65-deficient mice exhibit increased anxiety-like behaviors in the open field and elevated zero maze tests. Additionally, these mice fail to respond to the acute effects of benzodiazepines and have a diminished response to barbiturates, in the absence of postsynaptic compensation in GABA-A receptor function.
MATERIALS AND METHODS
Mice. The disruption of the mGAD65 locus by insertion of a phosphoglycerol kinase-driven neomycin-resistance cassette into the first exon, downstream of the transcription and translation start sites, has been described (9) . For these studies, mice were backcrossed for 4-7 generations onto the C57BL͞6 background. These mice exhibit infrequent stress-induced seizures (9) . Any mouse that had a seizure during or imme-diately before a test session was eliminated from the analysis for that session. Heterozygotes were intercrossed to generate GAD65ϩ͞ϩ and GAD65Ϫ͞Ϫ littermates. Adult male mice over 3 months of age were group-housed in a pathogen-free transgenic facility. Mice were maintained on a 12-hr light͞dark cycle with lights on from 0600 to 1800, with free access to water and rodent chow. Elevated zero maze. GAD65ϩ͞ϩ and GAD65Ϫ͞Ϫ mice (n ϭ 10 of each genotype) were analyzed for anxiety levels by using an elevated zero maze. This test is a pharmacologically validated assay of anxiety in animal models that is based on the natural aversion of mice to elevated open spaces (25, (28) (29) (30) . It is composed of a 6-cm wide ring with an outer diameter of 45 cm containing four equal quadrants of alternating walled (closed) or unwalled (open) sections. The entire ring is elevated to a height of 40 cm. Mice were placed in the walled region at the start of the 5-min test, and movements were analyzed by using a Poly-track video tracking system. Mice were considered to be in the open region when all four paws were entirely on the open portion of the maze.
Behavioral Pharmacology. Mice were pre-exposed to activity chambers for three (diazepam study) or five (muscimol study) sessions before the drug administration. The chambers consisted of an empty cage (45 cm ϫ 24 cm ϫ 18 cm) crossed with an array of photobeams to monitor horizontal movement (San Diego Instruments). A second rack of photobeams was used to monitor rearing activity. Diazepam (0.5, 1.5, or 4 mg͞kg), muscimol (0.5, 1.5, or 4 mg͞kg), or vehicle were administered i.p. after a 2-hr habituation period, and animals were monitored for an additional hour. Distance traveled in centimeters, active time (during which the subject is in motion), and rears were determined in 5-min time bins for the entire 3-hr period. Mice were acclimated in the activity boxes for up to 3 hr before the experiment to normalize baseline activity. Variability was minimized by testing only males at the same time of day with the same experimental protocol. Equal numbers of wild-type and GAD65-deficient mice were tested every 3 days with one drug dose in a within-subjects design, such that each mouse received each dose, with no other interruptions throughout the study. Doses were counterbalanced across test sessions. Testing occurred between 0700 and 1100.
Loss of Righting Ref lex. GAD65ϩ͞ϩ (n ϭ 8) and GAD65Ϫ͞Ϫ (n ϭ 7) mice one or two generations backcrossed onto a C57BL͞6 background received an i.p. injection of pentobarbital at a dose of 62 mg͞kg. Mice were placed in a V-shaped chamber, and the duration of the loss of righting reflex was assessed. Mice were considered to have regained the reflex when they could right themselves three times in a 30-sec time period.
Receptor Binding Studies. Mice were sacrificed, and their forebrains were quickly dissected out and homogenized in 50 vol of ice-cold 0.05 M Tris-citrate, pH 7.1. Nuclei and unbroken tissues were removed with a low-speed spin (1,000 ϫ g, 10 min, 4°C). Membranes were pelleted at 100,000 ϫ g for 1 hr at 4°C and washed three times with ice-cold 0.05 M Tris-citrate, pH 7.1 by resuspension and centrifugation at these conditions. Membranes were resuspended at 2 mg͞ml in the same buffer, and protein concentration was determined (BCAϩ method, Pierce). Membranes were stored at Ϫ70°C until use. In total, four membrane preparations, representing 6-8 mice of each genotype, were analyzed.
Receptor binding reactions were carried out with 500 mg of brain membranes͞ml in a final volume of 0.2 ml containing 0-400 nM 3 H-muscimol (8.1 Ci͞mmol, Amersham Pharmacia). Nonspecific binding was determined in the presence of 100 mM GABA. After incubation at 0-4°C for 1 hr, the reaction was filtered over a glass filter (GF͞B, Whatman), and unbound ligand was removed after vacuum filtration and three rapid washes with 5 ml of ice-cold 0.05 M Tris-citrate, pH 7.1. Filters were soaked in scintillation fluid counted on a standard 
RESULTS

GAD65؊͞؊ Mice Spend Less Time in the Central Region of the Open Field.
Open field testing revealed no differences in total activity between wild-type and GAD65-deficient mice (see Fig. 1A ). However, there were significant differences when regional distributions of activity were analyzed. ANOVA (Fig. 1C) .
GAD65؊͞؊ Mice Spend Less Time on the Open Quadrant of the Elevated Zero Maze. The elevated zero maze is based on the natural aversion of mice to open spaces and is sensitive to the effects of both anxiolytic and anxiogenic compounds (25, 28, 30) . It is a circular ring composed of four quadrants of alternating open and closed (walled) regions. As shown in Fig.  2A , there was a small decrease in total distance traveled on the maze for GAD65Ϫ͞Ϫ mice (23% decrease, P Ͻ 0.05 between genotypes, Student's t test). A regional breakdown revealed a Fig. 2C . Thus, for all variables examined here, GAD65Ϫ͞Ϫ mice avoid the open arm of the elevated zero maze and thus exhibit increased anxiety. The Response to the Anxiolytic Drug Diazepam Is Diminished in GAD65؊͞؊ Mice. GAD65Ϫ͞Ϫ mice were tested for their responses to the benzodiazepine diazepam, a compound that interacts with the GABA-A receptor and requires GABA for its effect (16, 19, 20) . Typically, wild-type mice exhibit increased locomotor activity in response to low doses of diazepam (1.5 mg͞kg), which often is interpreted as increased exploration caused by decreased anxiety (27, 30, 31) . Wild-type and GAD65-deficient mice were pre-exposed to the behavioral chambers three times before the experiment and for 2 hr in each session before i.p. drug administration. Although there was no difference in baseline activity levels, three-way ANOVA showed a statistically significant genotype by dose interaction [F(3,36) ϭ 5.2, P Ͻ 0.01] and a significant time by genotype interaction [F(4,48) ϭ 7.1, P Ͻ 0.01], which indicate that the dose-related temporal effects of diazepam depended on genotype. Follow-up comparisons indicated that GAD65-deficient mice showed a dramatically diminished response to diazepam (0.5 and 1.5 mg͞kg) as compared with wild-type mice (P Ͻ 0.05, Tukey test). Fig. 3 shows that after administration of diazepam (1.5 mg͞kg), wild-type mice exhibited a 2.5-fold increase in total distance traveled compared with vehicle at 15-min postinjection, and a 6-fold increase compared with GAD65Ϫ͞Ϫ mice (P Ͻ 0.05, Tukey test). This analysis revealed statistically significant differences between GAD65Ϫ͞Ϫ and GAD65ϩ͞ϩ mice at 10-, 15-, and 20-min postinjection (P Ͻ 0.05, Tukey test). Fig. 3 also shows that locomotor activity of wild-type mice, after the 1.5 mg͞kg dose of diazepam, differed significantly from vehicle at 10-and 15-min postinjection (P Ͻ 0.05, Tukey test). Locomotor activity of GAD65Ϫ͞Ϫ mice did not differ from vehicle at any time after administration of diazepam, indicating GAD65Ϫ͞Ϫ mice exhibit a diminished response to diazepam.
We previously have shown that there is no change in steady-state GABA content in adult C57BL͞6-backcrossed GAD65-deficient mice, even though there is a 50% decrease in cofactor-inducible GAD activity in brain extracts (9) . However, GAD65Ϫ͞Ϫ mice exhibit a 2.5-fold decrease in Kϩ-stimulated GABA release in vivo (11) . Thus, we reasoned that the dose-response curve to diazepam may be shifted in the GAD65Ϫ͞Ϫ mice to reflect a decrease in rapid GABA release. Different doses of diazepam were tested in wild-type and knockout mice, and the distance traveled in the first 10 min after drug administration is plotted as a function of dose in Fig.  4 . Two-way repeated measures ANOVA indicated a significant difference between genotype [F(1,12) ϭ 10.6, P Ͻ 0.01], as well as a significant effect for dose [F(3,36) ϭ 10.9, P Ͻ 0.001]. Wild-type mice showed a typical dose-response curve, with an increase in activity for the 0.5 mg͞kg dose and the maximum locomotor activation at 1.5 mg͞kg as compared with vehicle (P Ͻ 0.05, Tukey test). However, locomotor activity of GAD65Ϫ͞Ϫ mice did not differ from vehicle control at any of the doses of diazepam tested (Fig. 4) . Genotypic differences in response to diazepam were significant at both the 0.5 and 1.5 mg͞kg dose of diazepam (P Ͻ 0.05, Tukey test, Fig. 4) . Thus, instead of producing a shift in the dose-response curve, GAD65Ϫ͞Ϫ mice are insensitive to the locomotor activating effect of low doses of diazepam.
GAD65؊͞؊ Mice Exhibit a Diminished Response to Pentobarbital, Another Positive Modulator of GABAergic Neurotransmission. GAD65Ϫ͞Ϫ mice were tested for their response to a second modulator of GABAergic neurotransmission, the barbiturate pentobarbital, which enhances GABAinduced Cl Ϫ influx by GABA-A receptors (32). Mice were given an i.p. injection of pentobarbital (62 mg͞kg) and assessed for the duration of the loss of righting reflex (LORR). A mouse was judged to have regained this reflex when able to right itself three times in a 30-sec time period. As shown in Fig. 5 , GAD65Ϫ͞Ϫ mice showed a significant reduction in the duration of pentobarbital-induced LORR as compared with GAD65ϩ͞ϩ mice [30% reduction; Kruskal-Wallis ANOVA on Ranks, H(1) ϭ 6.5, P Ͻ 0.001]. Thus, as for benzodiazepines, GAD65-deficient mice exhibit an altered response to barbiturates. GABA-A Receptor Density Is Unchanged in GAD65-Deficient Mice. We assessed whether the loss of GAD65-generated GABA results in alterations in GABA-A receptor density or affinity to compensate for a possible defect in rapid GABA release. Receptor binding studies were performed by using brain membrane preparations from wild-type and knockout mice. Scatchard analysis revealed that the binding constants for 3 H-muscimol (a GABA-A receptor agonist that binds near the GABA site) are unchanged between genotypes (K d ; mean Ϯ SEM; GAD65ϩ͞ϩ 73 Ϯ 7 nM, GAD65Ϫ͞Ϫ 79 Ϯ 13 nM). There is also no difference in total number of binding sites (B max ; mean Ϯ SEM; GAD65ϩ͞ϩ, 2.24 Ϯ 0.14; GAD65Ϫ͞Ϫ, 2.25 Ϯ 0.33). Thus, there is no significant change in postsynaptic GABA-A receptor density in GAD65-deficient mice.
GAD65؊͞؊ Mice Exhibit Typical Behavioral Responses to the GABA-A Agonist Muscimol. If there is no postsynaptic GABA-A receptor alteration in GAD65-deficient mice, then there should be no change in behavioral response of GAD65-deficient mice to muscimol (which interacts with GABA-A receptors and exerts its effect in the absence of GABA). Wild-type mice exhibit a sedative effect in response to muscimol. Mice were exposed to the behavioral chambers for 3 hr before i.p. drug administration. Fig. 6 shows the distance traveled during a 30-min time period starting 15 min after drug administration for several doses of muscimol. Two-way repeated measures ANOVA, with a between subject factor for genotype, showed no significant difference in locomotor behavior between GAD65Ϫ͞Ϫ and GAD65ϩ͞ϩ mice in response to muscimol (0, 0.5, 1.5, and 4.0 mg͞kg). There was a significant effect of muscimol dosage [F(3,36) ϭ 7.8, P Ͻ 0.001] that was attributable to the effects of the 4.0 mg͞kg dose (Fig.  6) . Thus, we observed no locomotor activating effect of muscimol and no significant difference between genotypes.
However, both genotypes show the sedative effect of the drug at the 4 mg͞kg dose (P Ͻ 0.05, Tukey test). Thus, as predicted, GAD65Ϫ͞Ϫ mice do not respond differently to the GABA-A receptor agonist muscimol, an agent, which, in contrast to diazepam, does not rely on the presence of GABA for its effect.
DISCUSSION
A distinction between the roles of each of the highly homologous isoforms of the GABA-synthesizing enzyme GAD in inhibitory neurotransmission is starting to emerge. Thus, GAD67 is required for synthesizing sufficient levels of GABA to maintain essential functions that sustain life (12, 13) , whereas GAD65-generated GABA appears to be essential for regulating responses to environmental signals. We previously have shown that GAD65-deficient mice exhibit spontaneous seizures, which can be induced by mild stress (9) . Furthermore, GABA generated by GAD65 is critical for the loss of visual cortical responses that occur in an eye briefly deprived of vision (11) . Here we show that GAD65-deficient mice exhibit increased anxiety-like responses in two behavioral paradigms: the open field test and the elevated zero maze. The wild-type and knockout mice have been backcrossed onto the C57BL͞6 background for 4-7 generations and thus still contain some remaining genetic heterogeneity. This heterogeneity should be equally present in both the wild-type and knockout animals, thus highlighting the penetrance of the phenotype. The elevated zero maze, similar to the elevated plus maze, is used to screen compounds for anxiolytic or anxiogenic effects (25, (28) (29) (30) . Anxiolysis by diazepam typically results in hyperlocomotion (27, 30, 31) , which is considered an increase in exploratory activity on reduced anxiety. Additionally, GAD65Ϫ͞Ϫ mice show a loss of response to the locomotor activating effect of the benzodiazepine diazepam, which augments GABA function at GABA-A receptors. GAD65-deficient mice also exhibit a diminished response to the effects of barbiturates. Additionally, we show that there is no postsynaptic change in GABA-A receptor density, based on (i) the behavioral response to muscimol, an agent that acts at GABA-A receptors in the absence of endogenous GABA and (ii) radioligand receptor binding studies. Given that the receptor binding studies were done on crude brain homogenates, alterations in regional GABA-A receptor levels or subunit usage have not been excluded. Nevertheless, the increased anxiety and diminished responses to low doses of diazepam and the sedative dose of pentobarbital in GAD65Ϫ͞Ϫ mice are likely to be a direct effect of a lack of GAD65-generated GABA without a modulation by postsynaptic events. Based on these results, we propose that GAD65-generated GABA is involved in modulating responses to anxiogenic stimuli.
Alterations in GABAergic neurotransmission during times of stress have been proposed to modulate the stress response (33) (34) (35) (36) , which underlies the therapeutic activity of benzodiazepines in anxiety and stress management. The anxiety-like behavioral effects observed in the GAD65-deficient mice are consistent with the suggested role of GABAergic neurotransmission in animal models of anxiety. For instance, elevation of GABA levels, through inhibition of GABA transaminase (GABA-T), produces anxiolytic-like effects in numerous tests in animal models including conflict (37) , open field (38) , social interaction (24) , light͞dark exploration (39) , and elevated plus-maze (24) procedures. GABA reuptake inhibitors also have anxiolytic-like effects in punished drinking tests (e.g., refs. 40 and 41). Direct GABA-A agonists (e.g., muscimol) produce anxiolytic profiles in ethological models, such as the plus-maze (e.g., refs. 24, 42, and 43). Accordingly, the prototypical anxiolytic compound diazepam reduces anxiety in the elevated plus-maze (25) . Conversely, the noncompetitive GABA-A antagonist picrotoxin produces anxiety-like behav- (1999) ior in conditioned suppression (44) (45) (46) (47) (48) , social interaction (49), light͞dark exploration (27) , and elevated plus-maze (50) tests in animal models. The competitive GABA-A antagonist bicuculline also has been shown to increase anxiety in the elevated plus-maze (25) . Based on subcellular localization, membrane association, and cofactor association, GAD65 has been suggested to be involved in generating GABA for rapid release (2, 5, 51) . In fact, in vivo microdialysis experiments revealed a defect in GABA release on maximum Kϩ stimulation in GAD65Ϫ͞Ϫ mice (11) . We propose that elevated anxiety in GAD65Ϫ͞Ϫ animals represents a decrement in the ability of GAD65-deficient mice to rapidly release GABA during stressors, rather than changes in sensitivity of postsynaptic GABA-A receptors. In accord with this hypothesis, we find the activity of drugs that depend on endogenous GABA release are blunted in GAD65Ϫ͞Ϫ mice, whereas the effects of drugs that directly activate postsynaptic receptors appear unaffected in mutant animals. Thus, these animals provide a useful model for examining the role of GABAergic neurotransmission in responses to stress and anxiety.
